Analysts’ Viewpoint
Infusion therapy involves usage of sterilized needles and catheters to administer a drug via non-oral routes such as intramuscular injections and epidural routes. Rise in prevalence of chronic diseases, such as cancer, neurological diseases, and gastrointestinal diseases, is expected to drive the global market from 2021 to 2031. Increase in elderly population, changing infusion therapy demand environment, and severe orthopedic diseases are boosting the global infusion therapy market share.
Development of advanced, cost-effective, and user-friendly home infusion kits presents significant opportunities for manufacturers in the business in the next few years. Key players are focusing on strategies such as merger & acquisition, new product launches, and technological innovations to increase their market footprint.
Infusion therapy is used to treat medical conditions, such as infections and diseases, that do not respond to oral antibiotics. An infusion therapy provider is someone who specializes in administering infusion therapies to patients in their homes or other alternative settings. This is referred to as a home infusion therapy pharmacy. Comprehensive service, prescription drugs, and biologics can be safely and effectively administered in patients' homes or other locations.
Rise in hospital-acquired infections (HAIs), which are caused by contact with contaminated tools, bedclothes, and air droplets throughout facilities, is fueling market development. Furthermore, demand for home infusion therapy is rising to reduce the likelihood of infection and ensure the best possible care. Development of low-cost, user-friendly home infusion kits is another factor propelling the industry.
Request a sample to get extensive insights into the Infusion Therapy Market
Cancer is the second leading cause of death globally. It occurs due to development of abnormal cells, which further divide uncontrollably. These abnormal cells further form a mass like structure, which is called tumor. According to the WHO, cancer accounted for nearly 10 million deaths globally in 2020, which is one in six deaths. The most common cancers are breast, prostrate, lung colon, and rectum.
Diabetes is another chronic disease, which leads to large number of deaths. According to the Centers for Disease Control and Prevention, around 37 million people die in the U.S. due to diabetes.
Cardiovascular diseases are the leading causes of death globally. Heart attacks and strokes are the most common acute events. These are primarily caused due to blockages in the blood vessels, which prevent the blood from flowing to the brain or heart. The reasons for heart failure could include unhealthy diet and addictions such as tobacco and smoking. According to the WHO, in 2019, CVDs accounted for an estimated 17.9 million deaths; of these 85% were due to heart attack and stroke, and more than 75% deaths occur in the low & middle income countries.
Thus, rise in the number of infusion therapies due to the increase in incidence of these chronic diseases is driving the infusion therapy market size.
Infusion pumps are used in various applications in the medical field. In some cases, there are chances of getting an incorrect infusion into a patient’s body, which could hamper a patient's health. However, advanced pumps are available that directly deliver fluids or medications more efficiently into the patient’s blood stream. This minimizes human errors. Advanced pumps, such as ‘Sigma Spectrum’ and other smart pumps, contain drug libraries with a digital regulation within the pump itself to minimize the errors.
The two basic classes of infusion pumps are large volume pumps and small volume pumps. Large volume pumps are used to deliver nutrients, while small pumps are utilized to deliver medications and hormones. In the case of chemotherapy infusion, the medicines (of around 100 agents) used to treat cancer are introduced through a pump that controls the rate and amount of infusion. Generally, chemotherapy medications are infused through a vein in the patient’s hand or arm. However, these are sometimes infused through a specific port or are injected under the skin. These medications further circulate in the body and fight against the disease.
Therefore, usage of advanced infusion pumps, such as IP-200 infusion system, that can minimize errors is likely to propel market expansion.
Request a custom report on Infusion Therapy Market
In terms of product, the accessories segment dominated the global industry in 2021. The trend is expected to continue during the forecast period. According to a featured article by Wolters Kluwer Health, Inc., over 90% of hospitalized patients in the U.S. received IV medications, with the majority of them delivered via portable infusion pump.
Based on indication, the cancer segment led the global infusion therapy market in 2021. Just as the prevalence of target illnesses such as cancer, viral infections, and tuberculosis (TB) has increased, so has the usage of IV infusion pump accessories.
Infusion products are used to administer analgesics, anesthetics, antipyretics, antibiotics, anticancer medications, and other medications. Usage of medications to treat or eliminate cancer cells is one of the most commonly adopted cancer treatments. Chemotherapy fights cancer cells in various ways, including interfering with the ability of cancer cells to grow or reproduce. Cancer is also commonly treated with more than one medicine at the same time. Chemotherapy could be used alone or in combination with other treatments such as radiation or surgery.
In terms of therapy, the antibiotic/antiviral segment dominated the global market in 2021. The trend is expected to continue during the forecast period. Antibiotic intravenous (IV) infusion therapy is a common therapy in hospitals. It has gained popularity in the past few years, coinciding with the rise in bacterial resistance to several commonly used oral antibiotics. In these cases, antibiotic IV infusion therapy is the last line of defense against these types of bacteria, which are already one of the most serious threats to human health in the 21st century.
Based on end-user, the hospitals segment dominated the global market in 2021. The trend is expected to continue during the forecast period. New coronavirus strains have been reported in several parts of the world, resulting in rise in cases. This has increased the number of hospital admissions.
Many patients are being placed on ventilators for critical care, particularly the elderly and those with severe lung infections. Intravenous solutions are constantly administered to such patients in order to maintain adequate nutrition.
According to the infusion therapy industry report, North America held the largest share in 2021, led by the increase in medications used to treat chronic and uncommon diseases through infusion therapy. Rise in prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes; increase in geriatric population; and rapid technological advancements in the healthcare sector contribute to the region's global dominance.
Investment in the healthcare market in North America has increased in the past few years. Improved quality of life due to economic development has propelled market expansion in the region.
The market in Asia Pacific is expected to grow at a rapid pace during the forecast period owing to rapid adoption of new technologies in the infusion therapy industry and rise in prevalence of chronic diseases.
Leading companies in the global market are Becton, Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, ICU Medical, Inc., Fresenius SE & Co. KGaA, Medtronic, Inc., Terumo Corporation, CareFusion Corporation, and Polymedicure. These companies are focusing on strategic acquisitions and partnerships to expand their product portfolio.
Prominent players have been profiled in the infusion therapy market report based on parameters such as product portfolio, recent developments, financial overview, company overview, strategies, and segments.
|
Attribute |
Detail |
|
Size in 2021 |
US$ 41.7 Bn |
|
Forecast (Value) in 2031 |
More than US$ 78.9 Bn |
|
Compound Annual Growth Rate (CAGR) |
6.7% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global industry was valued at US$ 41.7 Bn in 2021
It is projected to reach more than US$ 78.9 Bn by 2031
The CAGR was 4.7% from 2017 to 2021
The CAGR is anticipated to be 6.7% from 2022 to 2031
Rise in prevalence of chronic diseases such as cardiovascular & cancer and reduction of human errors due to advanced infusion pumps
The accessories segment held more than 35.0% share in 2021
North America is expected to account for significant share during the forecast period.
Becton, Dickinson and Company, Baxter International, Inc., B. Braun Melsungen AG, ICU Medical, Inc., Fresenius SE & Co. KGaA, Medtronic, plc, Terumo Corporation, CareFusion Corporation, and Polymedicure
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Infusion Therapy Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Industry Developments
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Technological Advancements
5.4. Regulatory Scenario by Region/globally
5.5. Covid-19 Pandemic impact on the industry
6. Global Infusion Therapy Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Infusion Pumps
6.3.1.1. Ambulatory Infusion Pumps
6.3.1.2. Stationary Infusion Pumps
6.3.1.3. Syringe Infusion Pumps
6.3.1.4. Disposable Pumps
6.3.1.5. Large Volume Pumps
6.3.1.6. Elastomeric Pumps
6.3.2. Infusion Set
6.3.3. Accessories
6.4. Market Attractiveness Analysis, by Product
7. Global Infusion Therapy Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. Cancer
7.3.2. Gastrointestinal Diseases / Disorders
7.3.3. Congestive Heart Failure
7.3.4. Rheumatoid Arthritis
7.3.5. Hemophilia
7.3.6. Immune Deficiencies
7.3.7. Others
7.4. Market Attractiveness Analysis, by Indication
8. Global Infusion Therapy Market Analysis and Forecast, by Therapy Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Therapy Type, 2017–2031
8.3.1. Antibiotic/Antiviral
8.3.2. Anti-coagulation
8.3.3. Anti-emetics
8.3.4. Blood Component Stimulating Factor
8.3.5. Chemotherapy
8.3.6. Nutrition
8.3.7. Hydration
8.3.8. Pain Management
8.4. Market Attractiveness Analysis, by Therapy Type
9. Global Infusion Therapy Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Clinics
9.3.4. Homecare Settings
9.4. Market Attractiveness Analysis, by End-user
10. Global Infusion Therapy Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Infusion Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Infusion Pumps
11.2.1.1. Ambulatory Infusion Pumps
11.2.1.2. Stationary Infusion Pumps
11.2.1.3. Syringe Infusion Pumps
11.2.1.4. Disposable Pumps
11.2.1.5. Large Volume Pumps
11.2.1.6. Elastomeric Pumps
11.2.2. Infusion Set
11.2.3. Accessories
11.3. Market Value Forecast, by Indication, 2017–2031
11.3.1. Cancer
11.3.2. Gastrointestinal Diseases / Disorders
11.3.3. Congestive Heart Failure
11.3.4. Rheumatoid Arthritis
11.3.5. Hemophilia
11.3.6. Immune Deficiencies
11.3.7. Others
11.4. Market Value Forecast, by Therapy Type, 2017–2031
11.4.1. Antibiotic/Antiviral
11.4.2. Anti-coagulation
11.4.3. Anti-emetics
11.4.4. Blood Component Stimulating Factor
11.4.5. Chemotherapy
11.4.6. Nutrition
11.4.7. Hydration
11.4.8. Pain Management
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Clinics
11.5.4. Homecare Settings
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Indication
11.7.3. By Therapy Type
11.7.4. By End-user
11.7.5. By Country
12. Europe Infusion Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Infusion Pumps
12.2.1.1. Ambulatory Infusion Pumps
12.2.1.2. Stationary Infusion Pumps
12.2.1.3. Syringe Infusion Pumps
12.2.1.4. Disposable Pumps
12.2.1.5. Large Volume Pumps
12.2.1.6. Elastomeric Pumps
12.2.2. Infusion Set
12.2.3. Accessories
12.3. Market Value Forecast, by Indication, 2017–2031
12.3.1. Cancer
12.3.2. Gastrointestinal Diseases / Disorders
12.3.3. Congestive Heart Failure
12.3.4. Rheumatoid Arthritis
12.3.5. Hemophilia
12.3.6. Immune Deficiencies
12.3.7. Others
12.4. Market Value Forecast, by Therapy Type, 2017–2031
12.4.1. Antibiotic/Antiviral
12.4.2. Anti-coagulation
12.4.3. Anti-emetics
12.4.4. Blood Component Stimulating Factor
12.4.5. Chemotherapy
12.4.6. Nutrition
12.4.7. Hydration
12.4.8. Pain Management
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Clinics
12.5.4. Homecare Settings
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Indication
12.7.3. By Therapy Type
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Infusion Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Infusion Pumps
13.2.1.1. Ambulatory Infusion Pumps
13.2.1.2. Stationary Infusion Pumps
13.2.1.3. Syringe Infusion Pumps
13.2.1.4. Disposable Pumps
13.2.1.5. Large Volume Pumps
13.2.1.6. Elastomeric Pumps
13.2.2. Infusion Set
13.2.3. Accessories
13.3. Market Value Forecast, by Indication, 2017–2031
13.3.1. Cancer
13.3.2. Gastrointestinal Diseases / Disorders
13.3.3. Congestive Heart Failure
13.3.4. Rheumatoid Arthritis
13.3.5. Hemophilia
13.3.6. Immune Deficiencies
13.3.7. Others
13.4. Market Value Forecast, by Therapy Type, 2017–2031
13.4.1. Antibiotic/Antiviral
13.4.2. Anti-coagulation
13.4.3. Anti-emetics
13.4.4. Blood Component Stimulating Factor
13.4.5. Chemotherapy
13.4.6. Nutrition
13.4.7. Hydration
13.4.8. Pain Management
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Clinics
13.5.4. Homecare Settings
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Indication
13.7.3. By Therapy Type
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Infusion Therapy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Infusion Pumps
14.2.1.1. Ambulatory Infusion Pumps
14.2.1.2. Stationary Infusion Pumps
14.2.1.3. Syringe Infusion Pumps
14.2.1.4. Disposable Pumps
14.2.1.5. Large Volume Pumps
14.2.1.6. Elastomeric Pumps
14.2.2. Infusion Set
14.2.3. Accessories
14.3. Market Value Forecast, by Indication, 2017–2031
14.3.1. Cancer
14.3.2. Gastrointestinal Diseases / Disorders
14.3.3. Congestive Heart Failure
14.3.4. Rheumatoid Arthritis
14.3.5. Hemophilia
14.3.6. Immune Deficiencies
14.3.7. Others
14.4. Market Value Forecast, by Therapy Type, 2017–2031
14.4.1. Antibiotic/Antiviral
14.4.2. Anti-coagulation
14.4.3. Anti-emetics
14.4.4. Blood Component Stimulating Factor
14.4.5. Chemotherapy
14.4.6. Nutrition
14.4.7. Hydration
14.4.8. Pain Management
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Clinics
14.5.4. Homecare Settings
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Indication
14.7.3. By Therapy Type
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Infusion Therapy Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017–2031
15.2.1. Infusion Pumps
15.2.1.1. Ambulatory Infusion Pumps
15.2.1.2. Stationary Infusion Pumps
15.2.1.3. Syringe Infusion Pumps
15.2.1.4. Disposable Pumps
15.2.1.5. Large Volume Pumps
15.2.1.6. Elastomeric Pumps
15.2.2. Infusion Set
15.2.3. Accessories
15.3. Market Value Forecast, by Indication, 2017–2031
15.3.1. Cancer
15.3.2. Gastrointestinal Diseases / Disorders
15.3.3. Congestive Heart Failure
15.3.4. Rheumatoid Arthritis
15.3.5. Hemophilia
15.3.6. Immune Deficiencies
15.3.7. Others
15.4. Market Value Forecast, by Therapy Type, 2017–2031
15.4.1. Antibiotic/Antiviral
15.4.2. Anti-coagulation
15.4.3. Anti-emetics
15.4.4. Blood Component Stimulating Factor
15.4.5. Chemotherapy
15.4.6. Nutrition
15.4.7. Hydration
15.4.8. Pain Management
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Clinics
15.5.4. Homecare Settings
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Indication
15.7.3. By Therapy Type
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company, 2021
16.3. Company Profiles
16.3.1. B. Braun Melsungen AG
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Medtronic plc
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Becton, Dickinson and Company
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. ICU medical (Smiths Medical)
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Baxter International, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Polymedicure
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. BIO-MED
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Terumo Medical Corporation
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. MEDIPRIM GmbH
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Fresenius Kabi
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Cardinal Health
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
List of Tables
Table 01: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031
Table 02: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031
Table 03: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031
Table 04: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
Table 05: Global Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031
Table 06: Global Infusion Therapy Market Value (US$ Bn) Forecast, by Region, 2017–2031
Table 07: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Country, 2017–2031
Table 08: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031
Table 09: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031
Table 10: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031
Table 11: North America Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
Table 12: North America Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031
Table 13: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031
Table 15: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031
Table 16: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031
Table 17: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
Table 18: Europe Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031
Table 19: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
Table 20: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031
Table 21: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031
Table 22: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031
Table 23: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
Table 24: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031
Table 25: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031
Table 27: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031
Table 28: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031
Table 29: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
Table 30: Latin America Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031
Table 31: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031
Table 32: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Product, 2017–2031
Table 33: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Infusion Pumps, 2017–2031
Table 34: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Indication, 2017–2031
Table 35: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by Therapy, 2017–2031
Table 36: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Infusion Therapy Market Value Share, by Product, 2021 and 2031
Figure 02: Global Infusion Therapy Market Attractiveness Analysis, Product, 2022–2031
Figure 03: Global Infusion Therapy Market (US$ Bn), by Infusion Pumps, 2017–2031
Figure 04: Global Infusion Therapy Market (US$ Bn), by Infusion Set, 2017–2031
Figure 05: Global Infusion Therapy Market (US$ Bn), by Accessories, 2017–2031
Figure 06: Global Infusion Therapy Market, by Indication, 2021 and 2031
Figure 07: Global Infusion Therapy Market Attractiveness Analysis, Indication, 2022–2031
Figure 08: Global Infusion Therapy Market (US$ Bn), by Cancer, 2017–2031
Figure 09: Global Infusion Therapy Market (US$ Bn), by Gastrointestinal Diseases/Disorders, 2017–2031
Figure 10: Global Infusion Therapy Market (US$ Bn), by Congestive Heart Failure, 2017–2031
Figure 11: Global Infusion Therapy Market (US$ Bn), by Rheumatoid Arthritis, 2017–2031
Figure 12: Global Infusion Therapy Market (US$ Bn), by Hemophilia, 2017–2031
Figure 13: Global Infusion Therapy Market (US$ Bn), by Immune Deficiencies, 2017–2031
Figure 14: Global Infusion Therapy Market (US$ Bn), by Others, 2017–2031
Figure 15: Global Infusion Therapy Market, by Therapy, 2021 and 2031
Figure 16: Global Infusion Therapy Market Attractiveness Analysis, Therapy, 2022–2031
Figure 17: Global Infusion Therapy Market (US$ Bn), by Antibiotic/Antiviral, 2017–2031
Figure 18: Global Infusion Therapy Market (US$ Bn), by Anti-coagulation, 2017–2031
Figure 19: Global Infusion Therapy Market (US$ Bn), by Anti-emetics, 2017–2031
Figure 20: Global Infusion Therapy Market (US$ Bn), by Blood Component Stimulating Factor, 2017–2031
Figure 21: Global Infusion Therapy Market (US$ Bn), by Chemotherapy, 2017–2031
Figure 22: Global Infusion Therapy Market (US$ Bn), by Nutrition, 2017–2031
Figure 23: Global Infusion Therapy Market (US$ Bn), by Hydration, 2017–2031
Figure 24: Global Infusion Therapy Market (US$ Bn), by Pain Management, 2017–2031
Figure 25: Global Infusion Therapy Market, by End-user, 2021 and 2031
Figure 26: Global Infusion Therapy Market Attractiveness Analysis, End-user, 2022–2031
Figure 27: Global Infusion Therapy Market (US$ Bn), by Hospitals, 2017–2031
Figure 28: Global Infusion Therapy Market (US$ Bn), by Ambulatory Surgical Centers, 2017–2031
Figure 29: Global Infusion Therapy Market (US$ Bn), by Clinics, 2017–2031
Figure 30: Global Infusion Therapy Market (US$ Bn), by Homecare Settings, 2017–2031
Figure 31: Global Infusion Therapy Market Value Share Analysis, by Region, 2021 and 2031
Figure 32: Global Infusion Therapy Market Attractiveness Analysis, by Region, 2022–2031
Figure 33: North America Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 34: North America Infusion Therapy Market Value Share Analysis, by Country, 2021 and 2031
Figure 35: North America Infusion Therapy Market Attractiveness Analysis, by Country, 2022–2031
Figure 36: North America Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
Figure 37: North America Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031
Figure 38: North America Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
Figure 39: North America Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031
Figure 40: North America Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 41: North America Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 42: North America Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
Figure 43: North America Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 44: Europe Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 45: Europe Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 46: Europe Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 47: Europe Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
Figure 48: Europe Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031
Figure 49: Europe Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
Figure 50: Europe Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031
Figure 51: Europe Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 52: Europe Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 53: Europe Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
Figure 54: Europe Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 55: Asia Pacific Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 56: Asia Pacific Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 57: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 58: Asia Pacific Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
Figure 59: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031
Figure 60: Asia Pacific Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
Figure 61: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031
Figure 62: Asia Pacific Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 63: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 64: Asia Pacific Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
Figure 65: Asia Pacific Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 66: Latin America Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 67: Latin America Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 68: Latin America Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 69: Latin America Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
Figure 70: Latin America Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031
Figure 71: Latin America Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
Figure 72: Latin America Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031
Figure 73: Latin America Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 74: Latin America Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 75: Latin America Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
Figure 76: Latin America Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 77: Middle East & Africa Infusion Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 78: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 79: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 80: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Product, 2021 and 2031
Figure 81: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Product, 2022–2031
Figure 82: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Indication, 2021 and 2031
Figure 83: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Indication, 2022–2031
Figure 84: Middle East & Africa Infusion Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 85: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 86: Middle East & Africa Infusion Therapy Market Value Share Analysis, by End-user, 2021 and 2031
Figure 87: Middle East & Africa Infusion Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Infusion Therapy Market
